Pharmaceuticals market research reports by GlobalData

• Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Oct 15, 2023  |  Published by: GlobalData  |  USD 3,495

  Metachromatic Leukodystrophy (MLD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MLD therapeutics. More than 5,500 diagnosed prevalent cases of MLD are anticipa ... Read More

• Mexico Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Mexico Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Mexico Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Mexico Reversible Contraceptive Procedures. The databook report ... Read More

• Russia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Russia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Russia Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Russia Reversible Contraceptive Procedures. The databook report ... Read More

• Japan Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Japan Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Japan Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Reversible Contraceptive Procedures. The databook report pro ... Read More

• South Korea Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  South Korea Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “South Korea Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the South Korea Reversible Contraceptive Procedures. The d ... Read More

• Canada Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Canada Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Canada Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Canada Reversible Contraceptive Procedures. The databook report ... Read More

• Spain Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Spain Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Spain Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Spain Reversible Contraceptive Procedures. The databook report pro ... Read More

• China Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  China Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “China Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the China Reversible Contraceptive Procedures. The databook report pro ... Read More

• Brazil Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Brazil Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Brazil Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Brazil Reversible Contraceptive Procedures. The databook report ... Read More

• India Neurology Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 3,995

  India Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “India Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India Neurology Procedures. The databook report provides procedure volumes within segments - Dur ... Read More

• Japan Neurology Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 3,995

  Japan Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Japan Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Neurology Procedures. The databook report provides procedure volumes within segments - Dur ... Read More

• Australia Neurology Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 3,995

  Australia Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Australia Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Neurology Procedures. The databook report provides procedure volumes within se ... Read More

• Italy Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Italy Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Italy Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Italy Reversible Contraceptive Procedures. The databook report pro ... Read More

• Australia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  Australia Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Australia Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Reversible Contraceptive Procedures. The databoo ... Read More

• India Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Oct 13, 2023  |  Published by: GlobalData  |  USD 2,995

  India Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “India Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India Reversible Contraceptive Procedures. The databook report pro ... Read More

• Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032

  Oct 12, 2023  |  Published by: GlobalData  |  USD 14,995

  Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Heart Failure (HF) market through 2032. Gl ... Read More

• Acute Renal Failure (ARF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Oct 09, 2023  |  Published by: GlobalData  |  USD 3,495

  Acute Renal Failure (ARF) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ARF therapeutics. More than 18 million incident cases of ARF are anticipated in 2023 in ... Read More

• Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Oct 09, 2023  |  Published by: GlobalData  |  USD 3,495

  Dravet Syndrome (DS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DS therapeutics. More than 123,000 diagnosed prevalent cases of DS are anticipated in 2023 in ... Read More

• Crohn's Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032

  Oct 06, 2023  |  Published by: GlobalData  |  USD 14,995

  Crohn's Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, Canada) and provides an Excel-based forecast model for Crohn's Disease market through 2032. ... Read More

• Non-Alcoholic Steatohepatitis (NASH) Epidemiology Analysis and Forecast to 2032

  Oct 06, 2023  |  Published by: GlobalData  |  USD 3,995

  Non-Alcoholic Steatohepatitis (NASH) Epidemiology Analysis and Forecast to 2032 Summary Non-alcoholic steatohepatitis (NASH) is a subtype of non-alcoholic fatty liver disease (NAFLD) that is characterized by liver cell damage and inflammation (Sheka et al., 2020). NASH is often asymptomatic and is d ... Read More

• Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032

  Oct 05, 2023  |  Published by: GlobalData  |  USD 3,995

  Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032 Summary Seasonal influenza (SI) is a contagious respiratory viral illness. There are four types of SI viruses: A, B, C, and D; however, only types A and B cause human disease of public health concern (WHO, 2023). Influenza transm ... Read More

• Germany Reversible Contraceptive Procedures Count by Segments and Forecast to 2030

  Sep 30, 2023  |  Published by: GlobalData  |  USD 2,995

  Germany Reversible Contraceptive Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Germany Reversible Contraceptive Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Germany Reversible Contraceptive Procedures. The databook repo ... Read More

• Digital Marketing Trends in Colorectal Cancer

  Sep 30, 2023  |  Published by: GlobalData  |  USD 1,950

  Digital Marketing Trends in Colorectal Cancer Summary Merck’s Keytruda.com achieved the highest total traffic across CRC patient sites in the US, with over 3.3 million visitors from August 2022 to July 2023. This was followed by BMS’s Opdivo.com (1.7 million visits) and Roche’s Avastin.com (258,000 ... Read More

• Artificial Intelligence in Pharma - Impact, Trends, Key Players and Top AI Drugs

  Sep 30, 2023  |  Published by: GlobalData  |  USD 495

  Artificial Intelligence in Pharma - Impact, Trends, Key Players and Top AI Drugs Summary This report investigates the impacts and development of Artificial Intelligence within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and mov ... Read More

• Australia Speech Aid Devices Procedures Count by Segments and Forecast to 2030

  Sep 29, 2023  |  Published by: GlobalData  |  USD 2,995

  Australia Speech Aid Devices Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Australia Speech Aid Devices Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Speech Aid Devices Procedures. The databook report provides ... Read More

< prev 30 31 32 33 34 35 36 37 38 39 next >